We are happy to invite you to attend the First Nucleic Acid Therapeutics Conference, India-2025 (Supported by a Regional Society Delivery Grant from the Oligonucleotide Therapeutics Society) to be held at Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), Bengaluru, INDIA between February 18 and 21, 2025. This regional meeting effort has been successfully initiated by leaders like Dr. Richard Geary (Ionis Pharmaceuticals), Professor Masad Damha (McGill University), Professor David Corey (UT Southwestern), Dr. Rebecca Miles and Dr. Maja Janas.
Many international and national leaders from academia, industry and government have been invited to participate. The goal is to educate, spread the success and promise of Nucleic Acid medicine around the globe and reach out to younger scientists, students and post-docs.
We invite you to attend this conference. Abstracts are invited. Poster abstracts will be evaluated for best poster prizes. Financial assistance is available for eligible graduate students and post-docs and apply with your abstract.
Company Details
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.otsindiarm2025.in/
Nat-Rim'25 Questions
Nat-Rim'25's website is https://www.otsindiarm2025.in/
Nat-Rim'25's LinkedIn profile is https://www.linkedin.com/company/nat-rim-25
Nat-Rim'25's industry is
Biotechnology Research
Nat-Rim'25's top competitors are
Entropy Club (Uoh),
Nimbus Therapeutics,
Syngene International Limited,
Hitchhikersai,
Wao Federation,
Oligonucleotide Therapeutics Society,
Alnylam Pharmaceuticals,
Cadalu,
Larvol,
Savithru Technologies.
Nat-Rim'25's categories are Biotechnology Research
